Brain Health Virtual Reality Study

Sponsor
University of California, San Diego (Other)
Overall Status
Recruiting
CT.gov ID
NCT06124339
Collaborator
(none)
150
1
3
65.8
2.3

Study Details

Study Description

Brief Summary

The Interventions for Brain Health Virtual Reality Study is a NIH-funded clinical research trial at the University of California San Diego (UCSD) Health under the supervision of the study principal investigator Dr. Judy Pa. The overarching goal of this trial is to use a novel virtual reality (VR) based intervention that simultaneously engages physical and cognitive activity aimed at improving brain health and cognition in older adults. The investigators will compare 3 types of interventions: physical activity, VR cognitive activity, and combined VR physical and cognitive activity over 16 weeks to evaluate physical and brain health changes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity
  • Behavioral: Cognitive Activity (VR)
  • Behavioral: Physical and Cognitive Activity
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Interventions to Promote Brain Health Virtual Reality Study
Actual Study Start Date :
Aug 8, 2023
Anticipated Primary Completion Date :
Aug 8, 2028
Anticipated Study Completion Date :
Feb 1, 2029

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cognitive activity - VR spatial navigation only

VR spatial navigation program will consist of a spatial navigation program that increases difficulty and length per trial over time. Spatial navigation is the ability to navigate between multiple elements/landmarks widely used in computer games. A trial is a test of performance or quality of someone or something.

Behavioral: Cognitive Activity (VR)
There will be three sessions a week over the course of 16 weeks.

Active Comparator: Physical activity - Cycling only

The physical activity program will consist of a stationary bike cycling program. Each day will consist of a cycling program of varying levels of difficulty for 20-50 minutes.

Behavioral: Physical Activity
There will be three sessions a week over the course of 16 weeks.

Experimental: Combined, simultaneous physical and cognitive activity

The combined physical and cognitive activity VR program will consist of a spatial navigation program that increases difficulty and length per trial over time.

Behavioral: Physical and Cognitive Activity
There will be three sessions a week over the course of 16 weeks.

Outcome Measures

Primary Outcome Measures

  1. Hippocampal MRI [16 Weeks]

    The hippocampus has been shown to be a selectively vulnerable region in AD, and several studies, including our own, identified a dysfunctional brain signal in the hippocampus in MCI patients. We propose to examine the effects of exercise on remediating this hyperactive signal exhibited in MCI patients.

  2. MST memory performance [16 Weeks]

    With the study's primary focus on hippocampal function, we will use the Mnemonic Separation Task (MST), a hippocampus-dependent discrimination test of similar objects, as our primary cognitive outcome. The MST is a memory task designed to heavily tax memory processes for making fine discriminations between highly similar objects or unrelated objects.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. 50-85 years of age

  2. Fluent in English

  3. Can safely ride a stationary bike

Exclusion Criteria:
  1. Dementia

  2. History of a neurological disorder

  3. Severe sensory deficits

  4. Inability to perform intervention (e.g., inability to cycle safely)

  5. Contraindications to MRI scan (e.g., pacemaker)

  6. Fear of needles/ blood

  7. Prior history of fainting due to sight of needles of blood

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, San Diego San Diego California United States 92122

Sponsors and Collaborators

  • University of California, San Diego

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Judy Pa, Co-Director of ADCS, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT06124339
Other Study ID Numbers:
  • 803273
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Judy Pa, Co-Director of ADCS, University of California, San Diego
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2023